Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Briggs

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
Transplantation|October 5, 2011
Human leukocyte antigen antibody-incompatible renal transplantation: excellent medium-term outcomes with negative cytotoxic crossmatchRobert Higgins, David Lowe, Mark Hathaway, et al.
Transplantation Direct|July 15, 2017
The UK National Registry of ABO and HLA Antibody Incompatible Renal Transplantation: Pretransplant Factors Associated With Outcome in 879 TransplantsLaura Pankhurst, Alex Hudson, Lisa Mumford, et al.
JAMA|April 8, 2010
Association of caveolin-1 gene polymorphism with kidney transplant fibrosis and allograft failureJason Moore, Amy Jayne McKnight, Matthew J Simmonds, et al.
Transplantation|February 25, 2012
Human leukocyte antigen-specific antibodies and gamma-interferon stimulate human microvascular and glomerular endothelial cells to produce complement factor C4Rizwan Hamer, Guerman Molostvov, David Lowe, et al.
Journal of the American Society of Nephrology : JASN|October 16, 2012
Donor ABCB1 variant associates with increased risk for kidney allograft failureJason Moore, Amy Jayne McKnight, Bernd Döhler, et al.
Human Immunology|November 26, 2013
Profiling antibodies to class II HLA in transplant patient seraCurtis McMurtrey, Dave Lowe, Rico Buchli, et al.
Trials|January 23, 2014
Can a combined screening/treatment programme prevent premature failure of renal transplants due to chronic rejection in patients with HLA antibodies: study protocol for the multicentre randomised controlled OuTSMART trialAnthony Dorling, Irene Rebollo-Mesa, Rachel Hilton, et al.
Environmental Health Perspectives|January 6, 2010
Traffic-related air pollution, oxidative stress genes, and asthma (ECHRS)Francesc Castro-Giner, Nino Künzli, Bénédicte Jacquemin, et al.
International Journal of Immunogenetics|November 2, 2023
BSHI and BTS UK guideline on the detection of alloantibodies in solid organ (and islet) transplantationRichard Battle, Deborah Pritchard, Sarah Peacock, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 2, 2020
C3d-positive donor-specific antibodies have a role in pretransplant risk stratification of cross-match-positive HLA-incompatible renal transplantation: United Kingdom multicentre studyAdarsh Babu, Natasha Khovanova, Olivia Shaw, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Transplantation|October 5, 2011
Human leukocyte antigen antibody-incompatible renal transplantation: excellent medium-term outcomes with negative cytotoxic crossmatchRobert Higgins, David Lowe, Mark Hathaway, et al.
Transplantation Direct|July 15, 2017
The UK National Registry of ABO and HLA Antibody Incompatible Renal Transplantation: Pretransplant Factors Associated With Outcome in 879 TransplantsLaura Pankhurst, Alex Hudson, Lisa Mumford, et al.
JAMA|April 8, 2010
Association of caveolin-1 gene polymorphism with kidney transplant fibrosis and allograft failureJason Moore, Amy Jayne McKnight, Matthew J Simmonds, et al.
Transplantation|February 25, 2012
Human leukocyte antigen-specific antibodies and gamma-interferon stimulate human microvascular and glomerular endothelial cells to produce complement factor C4Rizwan Hamer, Guerman Molostvov, David Lowe, et al.
Journal of the American Society of Nephrology : JASN|October 16, 2012
Donor ABCB1 variant associates with increased risk for kidney allograft failureJason Moore, Amy Jayne McKnight, Bernd Döhler, et al.
Human Immunology|November 26, 2013
Profiling antibodies to class II HLA in transplant patient seraCurtis McMurtrey, Dave Lowe, Rico Buchli, et al.
Trials|January 23, 2014
Can a combined screening/treatment programme prevent premature failure of renal transplants due to chronic rejection in patients with HLA antibodies: study protocol for the multicentre randomised controlled OuTSMART trialAnthony Dorling, Irene Rebollo-Mesa, Rachel Hilton, et al.
Environmental Health Perspectives|January 6, 2010
Traffic-related air pollution, oxidative stress genes, and asthma (ECHRS)Francesc Castro-Giner, Nino Künzli, Bénédicte Jacquemin, et al.
International Journal of Immunogenetics|November 2, 2023
BSHI and BTS UK guideline on the detection of alloantibodies in solid organ (and islet) transplantationRichard Battle, Deborah Pritchard, Sarah Peacock, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 2, 2020
C3d-positive donor-specific antibodies have a role in pretransplant risk stratification of cross-match-positive HLA-incompatible renal transplantation: United Kingdom multicentre studyAdarsh Babu, Natasha Khovanova, Olivia Shaw, et al.
Pageof 10